共 46 条
- [8] Tumour size is the only predictive factor of distant recurrence after pathological complete response to neoadjuvant chemotherapy in patients with large operable or locally advanced breast cancers: A sub-study of EORTC 10994/BIG 1-00 phase III trial [J]. EUROPEAN JOURNAL OF CANCER, 2015, 51 (03) : 301 - 309